Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Identification of Risk Factors for Brain Recurrence in Patients With HER2-positive Localised Breast Cancer

NCT06358625 is registered in ClinicalTrials.gov with Center Eugene Marquis as lead sponsor.

NCT NCT06358625
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06358625 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Identification of Risk Factors for Brain Recurrence in Patients With HER2-positive Localised Breast Cancer
Lead sponsor
Center Eugene Marquis
Phase
Observational
Overall status
Recruiting
Start date
June 6, 2024
Completion date
June 6, 2031
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

her2-positive breast cancer